We should be well and truly over 250m+ at bank as of June 30. 243m as of end of March and we will have some reduction in R&D costs with 1 paused trial and 2 complete, although I imagine some of those costs will be shifted elsewhere. Options being converted adds some extra cash to the pile.
Quite a nice position to be in.
Ann: Application for quotation of securities - NEU, page-10
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.41 |
Change
-0.450(2.27%) |
Mkt cap ! $2.494B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.77 | $19.28 | $6.226M | 319.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 29 | $19.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.41 | 100 | 11 |
View Market Depth
| Last trade - 12.00pm 30/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |